A Study to Evaluate the Impact of Esomeprazole on Pharmacokinetics of Sonidegib in Healthy Volunteers

Trial Profile

A Study to Evaluate the Impact of Esomeprazole on Pharmacokinetics of Sonidegib in Healthy Volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 17 Jun 2016

At a glance

  • Drugs Sonidegib (Primary) ; Esomeprazole
  • Indications Basal cell cancer; Breast cancer; Chronic myeloid leukaemia; Graft-versus-host disease; Haematological malignancies; Liver cancer; Medulloblastoma; Multiple myeloma; Myelodysplastic syndromes; Myelofibrosis; Oesophageal cancer; Ovarian cancer; Pancreatic cancer; Prostate cancer; Solid tumours
  • Focus Pharmacokinetics
  • Most Recent Events

    • 17 Jun 2016 New trial record
    • 08 Jun 2016 Results published in the British Journal of Clinical Pharmacology
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top